Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • 9Spokes shares surge with 5-year Visa partnership inked
    • News

    9Spokes shares surge with 5-year Visa partnership inked

    New Zealand-based fintech company 9Spokes (ASX: 9SP) has secured its most significant corporate deal to date having entered into a partnership with Visa, who will offer the 9Spokes platform to small business merchants worldwide.  Under terms of the 5-year agreement, Visa USA Inc will promote the 9Spokes business management platform to Visa clients and small

    Read More
    Public
  • CannPal trials confirm cannabis good for dog health and immunity
    • News

    CannPal trials confirm cannabis good for dog health and immunity

    Animal health company CannPal Animal Therapeutics (ASX: CP1) is proving that the health benefits of medicinal cannabis extend beyond the human realm with their latest trials confirming the safety of DermaCann® as a natural treatment for dermatitis and immune function in canines. Applying two different formulations of DermaCann® between 13 dogs, CannPal reported a substantial

    Read More
    Public
  • Flexigroup humm-ing along with 315% rise in BNPL transaction volumes
    • News

    Flexigroup humm-ing along with 315% rise in BNPL transaction volumes

    The pioneer of Australia’s buy-now-pay-later sector has reported a big uptake in adoption since Flexigroup (ASX: FXL) consolidated its BNPL businesses with retail-focused brand humm delivering a 315% rise in transaction volumes through the June quarter.  As the key differentiator against its competitors, humm allows customers to make interest-free purchases of up to $30,000. This

    Read More
    Public
  • Crowd Media achieves $2.7m turnaround, eyes billion-dollar tech breakthrough
    • News

    Crowd Media achieves $2.7m turnaround, eyes billion-dollar tech breakthrough

    Digital marketing and eCommerce company Crowd Media (ASX: CM8) has reported a significant financial turnaround with the company expected to report positive underlying EBITDA for FY20 which represented a $2.7m turnaround for the microcap.   The turnaround from a $2.6m loss in underlying EBITDA in FY19 comes in line with the appointment of industry leader Steven

    Read More
    Public
  • IPO Watch July: Aroa Biosurgery
    • Opinion

    IPO Watch July: Aroa Biosurgery

    Soft tissue regeneration company, Aroa Biosurgery, is set to list on the ASX at the end of the month. The company is looking to raise $45m at an offer price of $0.75, ultimately giving the Auckland-based company a proposed market capitalisation of $225m. Aroa’s technology is centred around soft tissue regeneration and the complex wound

    Read More
    Public
  • NTD becomes largest tyre wholesaler in Aus & NZ with T4U acquisition
    • News

    NTD becomes largest tyre wholesaler in Aus & NZ with T4U acquisition

    Tough trading conditions brought upon by drought, bushfires and a pandemic has prompted a major industry merger with Tyres 4U (T4U) and National Tyre & Wheel (ASX: NTD) set to become the largest independent multi branded tyre wholesaler across the Tasman. The merger will see NTD acquire all business assets of T4U in Australia and

    Read More
    Public
  • «
  • ‹
  • 592
  • 593
  • 594
  • 595
  • 596
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.